London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Safety and efficacy of PresbyMAX laser PRK in the treatment of presbyopia: four year results

Poster Details

First Author: H.Mahmood BAHRAIN

Co Author(s):    V. Radish   S. Mani           

Abstract Details


To study safety and efficacy of presbymax laser PRK in treating presbyopia.


Dr Haifa Eye Hospital


265 eyes of 137 patients with presbyopia ± refractive errors were included in a prospective study in Dr.Haifa Eye Hospital in Bahrain. Presbymax (Schwind eyetech-solutions, Kleinostheim, Germany) was performed on all eyes. Patients age was 49.5±4.57 years. Preoperative LogMAR uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected near visual acuity (UNVA), corrected near visual acuity (CNVA), distance spherical equivalent (DSE) and near spherical equivalent (NSE)were 0.7±0.36, 0.01±0.04, 0.4±0.35, 0.01±0.04, 43.63±1.72D, -0.24±3.17D and 1.46±3.37D respectively. All patients completed mor 4 years follow-up.


4 years postoperatively, UDVA, CDVA, UNVA, DSE and NSE were 0.1±0.12 (p<0.05), 0.11±0.12 (p<0.05), 0.02±0.05 (p<0.05), -0.43±0.64 (p<0.05) and 0.25±0.1 (p<0.05) respectively.


Presbymax is a safe and effective treatment of presbyopia with or without refractive errors. FINANCIAL INTEREST: NONE

Back to Poster listing